BioMarin Blows Past Q1 Estimates, Projects 1st Year of Profitability in 2020 [The Motley Fool]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: The Motley Fool
Investors looking for something of a safe haven in the COVID-9 storm might likeBioMarin Pharmaceutical(NASDAQ:BMRNBioMarin could pick up even more momentum now. The company announced its first-quarter results after the market closed on Wednesday. Here are the highlights from BioMarin's Q update.Image source: Getty Images.By the numbersBioMarin announced Q revenue of $0. million, a % jump from the $00.7 million reported in the same quarter of 09. This result also handily beat the average analysts' revenue estimate of $68.8 million.The company reported net income in the first quarter of $8. million, or $0. per share, based on generally accepted accounting principles (GAAPBioMarin's adjusted net income in the first quarter totaled $6. million. This translated to adjusted earnings of $0.6 per share based on the biotech's weighted average of its outstanding diluted common shares. The company's adjusted earnings per share (EPS) trounced the consensus Wall Street estimate of $0.0 per share.B
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- Making U.S. biotech more competitive with China's could help rare disease patients, experts say [CNBC]CNBC
- Does BioMarin Pharmaceutical (BMRN) Price Weakness Contrast With Its Cash Flow Valuation? [Yahoo! Finance]Yahoo! Finance
- BMRN or TARS: Which Is the Better Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical touts $3.2B 2025 revenue, Voxzogo surge and Amicus deal at JPM Conference [Yahoo! Finance]Yahoo! Finance
- BioMarin Appoints Arpit Davé Chief Digital and Information Officer [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 10/27/25 - Miss
BMRN
Sec Filings
- 1/12/26 - Form 8-K
- 12/22/25 - Form 8-K
- 12/19/25 - Form 8-K
- BMRN's page on the SEC website